Clinical Trial Update: Randomized Trial of EUS Neurolysis in Pancreas Cancer [Phase 3]

View source ↗

Summary

Phase 3 randomized trial evaluating endoscopic ultrasound neurolysis in pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Pancreatic Neoplasms | Phase 3 | Status: COMPLETED